Your browser doesn't support javascript.
Deployment of a New CRRT/PIRRT Device during the COVID-19 Pandemic Emergency: Organizational Challenges and Implementation Results.
Yessayan, Lenar T; Heung, Michael; Girard, Francine A; Shaikhouni, Salma; Szamosfalvi, Balazs.
  • Yessayan LT; Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA, lenar@umich.edu.
  • Heung M; Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Girard FA; Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Shaikhouni S; Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Szamosfalvi B; Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Blood Purif ; 50(3): 390-398, 2021.
Article in English | MEDLINE | ID: covidwho-917824
ABSTRACT

INTRODUCTION:

The coronavirus disease 2019 (COVID-19) pandemic led to increased demand nationwide for dialysis equipment, including supplies and machines. To meet the demand in our institution, our surge plan included rapid mobilization of a novel continuous renal replacement treatment (CRRT) machine named SAMI. The SAMI is a push-pull filtration enhanced dialysis machine that can conjugate extremely high single-pass solute removal efficiency with very precise fluid balance control. MATERIAL AND

METHODS:

Machine assembly was conducted on-site by local biomedical engineers with remote assistance by the vendor. One 3-h virtual training session of 3 dialysis nurses was conducted before SAMI deployment. The SAMI was deployed in prolonged intermittent replacement therapy (PIRRT) mode to maximize patients covered per machine per day. Live on-demand vendor support was provided to troubleshoot any issues for the first few cases. After 4 weeks of the SAMI implementation, data on treatments with the SAMI were collected, and a questionnaire was provided to the nurse trainees to assess device usability.

RESULTS:

On-site installation of the SAMI was accomplished with remote assistance. Delivery of remote training was successfully achieved. 23 PIRRT treatments were conducted in 10 patients. 7/10 of patients had CO-VID-19. The median PIRRT dose was 50 mL/kg/h (IQR [interquartile range] 44 - 62 mL/kg/h), and duration of the treatment was 8 h (IQR 6.3 - 8 h). Solute control was adequate. The user response was favorable to the set of usability questions involving user interface, on-screen instructions, machine setup, troubleshooting, and the ease of moving the machine.

CONCLUSION:

Assembly of the SAMI and training of nurses remotely are possible when access to vendor employees is restricted during states of emergency. The successful deployment of the SAMI in our institution during the pandemic with only 3-h virtual training supports that operating the SAMI is simple and safe.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Acute Kidney Injury / Pandemics / Continuous Renal Replacement Therapy / Intermittent Renal Replacement Therapy / SARS-CoV-2 / COVID-19 / Hemodialysis Units, Hospital Type of study: Observational study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: Blood Purif Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Acute Kidney Injury / Pandemics / Continuous Renal Replacement Therapy / Intermittent Renal Replacement Therapy / SARS-CoV-2 / COVID-19 / Hemodialysis Units, Hospital Type of study: Observational study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: Blood Purif Year: 2021 Document Type: Article